Ashley Cordova bought $997k of NVCR
Chief Executive Officer at NovoCure Ltd. 81,550 shares at an average of $12.22, traded Sep 5, 2025, filed Sep 8, 2025.
Score components
- +25RoleCEO
- +25Trade size$997k at market
- +6Relative to holdingsHoldings up 23%
- +8Price context63% below the 52-week high
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001562180-25-006130, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 5, 2025 | POpen-market purchase Ordinary Shares | +81,550 | $12.22 | $997k | 437,569 | Sep 8, 2025 |
Related signals
Other insiders at NovoCure Ltd and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 46Moderate | NovoCure Ltd | Christoph Brackmann Chief Financial Officer | $85k 6,412 shares | -3% | |
| 64Notable | NovoCure Ltd | William F Doyle Executive Chairman | $933k 71,887 shares | -18% | |
| 48Moderate | NovoCure Ltd | Frank X Leonard Chief Executive Officer | $75k 5,607 shares | -1% | |
| 30Weak | NovoCure Ltd | Nicolas Leupin Former Chief Medical Officer | $15k 1,100 shares | -1% | |
| 39Weak | NovoCure Ltd | Uri Weinberg Chf Medical and Innovation Ofr | $85k 6,412 shares | -2% | |
| 30Weak | NovoCure Ltd | Michal Nath Puri Chief Human Resources Officer | $15k 1,100 shares | -1% | |
| 65Notable | NovoCure Ltd | Mukund Paravasthu Chief Operating Officer | $667k 48,623 shares | -40% | |
| 53Moderate | NovoCure Ltd | Frank X Leonard Chief Executive Officer | $231k 16,966 shares | -5% | |
| 30Weak | NovoCure Ltd | Nicolas Leupin Former Chief Medical Officer | $14k 1,029 shares | -1% | |
| 41Moderate | NovoCure Ltd | Uri Weinberg Chf Medical and Innovation Ofr | $147k 10,733 shares | -5% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.